Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Director/PDMR Shareholding

27 Oct 2017 17:15

RNS Number : 8910U
Quixant PLC
27 October 2017
 

Quixant plc

("Quixant" or the "Company")

 

Issue of Equity and Director/PDMR Shareholding

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms for gaming and slot machine applications and accessories, today announces that it has applied to the London Stock Exchange for 105,000 ordinary shares of £0.001 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to exercises of options over Ordinary Shares ("Options") by certain Directors', persons discharging managerial responsibilities ("PDMR's") and employees of the Company.

 

On 27 October 2017, Cresten Preddy, Finance Director of the Company, exercised Options on 10,000 Ordinary Shares. On Admission Cresten Preddy will hold 40,000 Ordinary Shares, representing approximately 0.06% of the Company's issued share capital.

 

Furthermore, on 27 October 2017 the following PDMR's of the Company exercised Options and subsequently sold Ordinary Shares (in certain cases) as follows:

 

PDMR

Role

Options exercised

Ordinary Shares subsequently sold

John Malin

Sales Director, Quixant UK Ltd

5,000

5,000

Sandra Lowman

Operations Director, Quixant UK Ltd

33,000

-

Amit Sharma

Vice President Sales & General Manager, Quixant USA Inc

18,000

18,000

 

Total Voting Rights

It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 2 November 2017. On Admission the Company's issued share capital will comprise 66,034,982 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 66,034,982 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Operating Officer

Nominated Adviser and Broker:

Tel: +44 (0)20 7220 0500

finnCap

Matt Goode / Grant Bergman (Corporate Finance)

Simon Johnson / Alice Lane (Corporate Broking)

Financial PR:

Alma PR

Tel: +44 (0)20 8004 4217

John Coles

Hilary Buchanan

Susie Hudson

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP much of which is copyright protected.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

- Cresten Preddy - Finance Director

- John Malin - Sales Director, Quixant UK Ltd

- Sandra Lowman - Operations Director, Quixant UK Ltd

- Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

2.

Reason for the notification

a)

Position/status:

PDMR's

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERWSQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Exercise of Options over Ordinary Shares

c)

Price(s) and volume(s):

- Cresten Preddy

Price(s)

Volume(s)

49 pence

10,000

 

- John Malin

Price(s)

Volume(s)

49 pence

5,000

 

- Sandra Lowman

Price(s)

Volume(s)

49 pence

33,000

 

- Amit Sharma

Price(s)

Volume(s)

49 pence

18,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

e)

Date of the transaction:

27 October 2017

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

- John Malin - Sales Director, Quixant UK Ltd

- Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

2.

Reason for the notification

a)

Position/status:

PDMR's

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERWSQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Sale of Ordinary Shares

c)

Price(s) and volume(s):

- John Malin

Price(s)

Volume(s)

£4.458254 pence

5,000

 

- Amit Sharma

Price(s)

Volume(s)

£4.458254 pence

18,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

e)

Date of the transaction:

27 October 2017

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMMMZGVNGGNZM
Date   Source Headline
15th Mar 20177:00 amRNSSenior Management Update
2nd Mar 20177:00 amRNSNotice of Results
27th Jan 20177:00 amRNSTrading Update and Notice of Results
22nd Dec 201611:16 amRNSHolding(s) in Company
20th Dec 20165:06 pmRNSResult of Placing
20th Dec 20163:04 pmRNSProposed Secondary Placing
24th Nov 20162:05 pmRNSSecond Price Monitoring Extn
24th Nov 20162:00 pmRNSPrice Monitoring Extension
24th Nov 201611:05 amRNSSecond Price Monitoring Extn
24th Nov 201611:00 amRNSPrice Monitoring Extension
24th Nov 20167:00 amRNSTrading Update
21st Nov 20163:26 pmRNSAppointment of Company Secretary
27th Oct 20166:27 pmRNSHolding(s) in Company
19th Oct 20164:54 pmRNSIssue of Equity
6th Oct 20161:38 pmRNSIssue of Equity
21st Sep 20165:03 pmRNSHolding(s) in Company
14th Sep 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSNotice of Interim Results
27th Jul 20167:00 amRNSTrading Update and Notice of Results
20th Jun 20167:00 amRNSBoard Appointment
15th Jun 20164:57 pmRNSDirector Dealing
9th Jun 20164:32 pmRNSIssue of Equity
7th Jun 20167:00 amRNSHolding(s) in Company
23rd May 20168:17 amRNSSigning of Multi-Year Contract
26th Apr 201611:46 amRNSResult of AGM
6th Apr 20166:18 pmRNSDirector Dealing
6th Apr 20167:00 amRNSHolding(s) in Company
4th Apr 201610:53 amRNSCompleted Secondary Placing
23rd Mar 20167:00 amRNSFinal Results
19th Feb 20167:00 amRNSNotice of Results
15th Feb 201611:29 amRNSHolding(s) in Company
21st Jan 20167:00 amRNSTrading Update
13th Nov 20159:32 amRNSHolding(s) in Company
11th Nov 20157:00 amRNSCompletion of Acquisition
10th Nov 20153:40 pmRNSScheme of Arrangement Becomes Effective
6th Nov 201511:33 amRNSScheme of Arrangement Sanctioned By Court
3rd Nov 20155:13 pmRNSResults of Court Meeting and General Meeting
9th Oct 20157:00 amRNSPosting of Scheme Document
2nd Oct 201510:33 amRNSHolding in Company
1st Oct 20153:36 pmRNSForm 8 (OPD) Densitron Technologies plc
30th Sep 20153:33 pmRNSForm 8 (OPD) Quixant plc
25th Sep 20157:00 amRNSRule 2.7 Announcement
16th Sep 20157:00 amRNSHalf Yearly Report
3rd Aug 20159:48 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Update and Notice of Results
21st Apr 20157:00 amRNSQueen's Award for Enterprise
16th Apr 201511:01 amRNSResult of AGM
24th Mar 20151:41 pmRNSPosting of Annual Report and Accounts
24th Mar 20157:00 amRNSFinal Results
4th Mar 20157:00 amRNSNotice of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.